Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hong Nguyen

Showing results (151-160 of 207) with videos related to

Pageof 21
Sort By:
Research Square|April 17, 2023
Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood culturesHassan Badrane, Shaoji Cheng, Christopher L Dupont, et al.
Transplantation|July 26, 2019
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway AspergillosisHarisudhan Thanukrishnan, Timothy E Corcoran, Carlo J Iasella, et al.
Journal of Clinical Microbiology|April 13, 2007
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipientsCornelius J Clancy, Reia A Jaber, Helen L Leather, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicityDimitra Mitsani, M Hong Nguyen, Ryan K Shields, et al.
Nature Communications|September 22, 2023
Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood culturesHassan Badrane, Shaoji Cheng, Christopher L Dupont, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2015
Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent MechanismNatasha Whibley, Jillian R Jaycox, Delyth Reid, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2021
<i>In Vitro</i> Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-TazobactamAbigail M Rubio, Ellen G Kline, Chelsea E Jones, et al.
Open Forum Infectious Diseases|July 18, 2025
COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis-Results of the Prospective MSG-017 StudyM Hong Nguyen, Sixto M Leal, Luis Ostrosky-Zeichner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of ResistanceGhady Haidar, Nathan J Philips, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2014
Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agentsReem Almaghrabi, Cornelius J Clancy, Yohei Doi, et al.
Pageof 21

Showing results (151-160 of 207) with videos related to

Sort By:
Pageof 21
Research Square|April 17, 2023
Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood culturesHassan Badrane, Shaoji Cheng, Christopher L Dupont, et al.
Transplantation|July 26, 2019
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway AspergillosisHarisudhan Thanukrishnan, Timothy E Corcoran, Carlo J Iasella, et al.
Journal of Clinical Microbiology|April 13, 2007
Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipientsCornelius J Clancy, Reia A Jaber, Helen L Leather, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicityDimitra Mitsani, M Hong Nguyen, Ryan K Shields, et al.
Nature Communications|September 22, 2023
Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood culturesHassan Badrane, Shaoji Cheng, Christopher L Dupont, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2015
Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent MechanismNatasha Whibley, Jillian R Jaycox, Delyth Reid, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2021
<i>In Vitro</i> Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-TazobactamAbigail M Rubio, Ellen G Kline, Chelsea E Jones, et al.
Open Forum Infectious Diseases|July 18, 2025
COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis-Results of the Prospective MSG-017 StudyM Hong Nguyen, Sixto M Leal, Luis Ostrosky-Zeichner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of ResistanceGhady Haidar, Nathan J Philips, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy|May 29, 2014
Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agentsReem Almaghrabi, Cornelius J Clancy, Yohei Doi, et al.
Pageof 21